These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30177233)

  • 1. Inhibition of prolyl hydroxylases alters cell metabolism and reverses pre-existing diastolic dysfunction in mice.
    He X; Zeng H; Roman RJ; Chen JX
    Int J Cardiol; 2018 Dec; 272():281-287. PubMed ID: 30177233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic hypoxia mimicry enhances axonal regeneration and functional recovery following peripheral nerve injury.
    Smaila BD; Holland SD; Babaeijandaghi F; Henderson HG; Rossi FMV; Ramer MS
    Exp Neurol; 2020 Dec; 334():113436. PubMed ID: 32814068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats.
    Kato S; Takahashi T; Miyata N; Roman RJ
    J Pharmacol Exp Ther; 2020 Feb; 372(2):166-174. PubMed ID: 31801803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction.
    He X; Zeng H; Chen ST; Roman RJ; Aschner JL; Didion S; Chen JX
    J Mol Cell Cardiol; 2017 Nov; 112():104-113. PubMed ID: 28935506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair.
    Ghadge SK; Messner M; Van Pham T; Doppelhammer M; Petry A; Görlach A; Husse B; Franz WM; Zaruba MM
    J Mol Med (Berl); 2017 Aug; 95(8):825-837. PubMed ID: 28550361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
    Seo K; Seo S; Ki SH; Shin SM
    Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.
    Koivunen P; Serpi R; Dimova EY
    Pharmacol Res; 2016 Dec; 114():265-273. PubMed ID: 27832958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits.
    Zhou J; Li J; Rosenbaum DM; Zhuang J; Poon C; Qin P; Rivera K; Lepore J; Willette RN; Hu E; Barone FC
    PLoS One; 2017; 12(9):e0184049. PubMed ID: 28880966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia inhibits TNF-α-induced TSLP expression in keratinocytes.
    Tashiro N; Segawa R; Tobita R; Asakawa S; Mizuno N; Hiratsuka M; Hirasawa N
    PLoS One; 2019; 14(11):e0224705. PubMed ID: 31682627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications.
    Kim SY; Yang EG
    Molecules; 2015 Nov; 20(11):20551-68. PubMed ID: 26610437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl-hydroxylase inhibition preserves endothelial cell function in a rat model of vascular ischemia reperfusion injury.
    Barnucz E; Veres G; Hegedűs P; Klein S; Zöller R; Radovits T; Korkmaz S; Horkay F; Merkely B; Karck M; Szabó G
    J Pharmacol Exp Ther; 2013 Apr; 345(1):25-31. PubMed ID: 23388095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases Early Gastrointestinal GVHD in Experimental Allogeneic Hematopoietic Cell Transplantation.
    Palaniyandi S; Kumari R; Venniyil Radhakrishnan S; Strattan E; Hakim N; Munker R; Kesler MV; Hildebrandt GC
    Transplantation; 2020 Dec; 104(12):2507-2515. PubMed ID: 32639407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1α activation results in actin cytoskeleton reorganization and modulation of Rac-1 signaling in endothelial cells.
    Weidemann A; Breyer J; Rehm M; Eckardt KU; Daniel C; Cicha I; Giehl K; Goppelt-Struebe M
    Cell Commun Signal; 2013 Oct; 11():80. PubMed ID: 24144209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endurance training prevents negative effects of the hypoxia mimetic dimethyloxalylglycine on cardiac and skeletal muscle function.
    Favier FB; Britto FA; Ponçon B; Begue G; Chabi B; Reboul C; Meyer G; Py G
    J Appl Physiol (1985); 2016 Feb; 120(4):455-63. PubMed ID: 26679609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes.
    Stoehr A; Yang Y; Patel S; Evangelista AM; Aponte A; Wang G; Liu P; Boylston J; Kloner PH; Lin Y; Gucek M; Zhu J; Murphy E
    Cardiovasc Res; 2016 Jun; 110(3):346-58. PubMed ID: 27095734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of HIF in cobalt-induced ischemic tolerance.
    Jones SM; Novak AE; Elliott JP
    Neuroscience; 2013 Nov; 252():420-30. PubMed ID: 23916558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis.
    Bakshi HA; Mishra V; Satija S; Mehta M; Hakkim FL; Kesharwani P; Dua K; Chellappan DK; Charbe NB; Shrivastava G; Rajeshkumar S; Aljabali AA; Al-Trad B; Pabreja K; Tambuwala MM
    Inflammation; 2019 Dec; 42(6):2032-2036. PubMed ID: 31377947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus.
    Wall AM; Corcoran AE; O'Halloran KD; O'Connor JJ
    Neurobiol Dis; 2014 Feb; 62():8-17. PubMed ID: 24055213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection.
    Requena-Ibáñez JA; Santos-Gallego CG; Rodriguez-Cordero A; Zafar MU; Badimon JJ
    Cardiovasc Drugs Ther; 2022 Dec; 36(6):1187-1196. PubMed ID: 34533692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Glucose Activates Prolyl Hydroxylases and Disrupts HIF-α Signaling via the P53/TIGAR Pathway in Cardiomyocyte.
    Chen JX; Li L; Cantrell AC; Williams QA; Zeng H
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.